Invention Grant
- Patent Title: Fusion proteins
- Patent Title (中): 融合蛋白
-
Application No.: US11792076Application Date: 2005-12-01
-
Publication No.: US08124074B2Publication Date: 2012-02-28
- Inventor: Keith Alan Foster , John Chaddock , Philip Marks , Patrick Stancombe , Lyndsey Durose
- Applicant: Keith Alan Foster , John Chaddock , Philip Marks , Patrick Stancombe , Lyndsey Durose
- Applicant Address: GB Abingdon, Oxfordshire
- Assignee: Syntaxin Limited
- Current Assignee: Syntaxin Limited
- Current Assignee Address: GB Abingdon, Oxfordshire
- Agency: Morris, Manning & Martin, LLP
- Agent Christopher W. Raimund
- Priority: GB0426397.6 20041201
- International Application: PCT/GB2005/004606 WO 20051201
- International Announcement: WO2006/059113 WO 20060608
- Main IPC: C12N9/50
- IPC: C12N9/50 ; C12N15/11 ; C12N15/62 ; C07K14/00 ; A61K38/48 ; C12P21/02 ; A61P37/00 ; A61P19/00 ; A61P9/00 ; A61P1/00

Abstract:
The invention provides a single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a target cell; a Targeting Moiety that is capable of binding to a Binding Site on the target cell, which Binding Site is capable of undergoing endocytosis to be incorporated into an endocome within the target cell; a protease cleaving site at which site the fusion protein is cleavable by the protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the Targeting Moiety; and the translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the target cell.
Public/Granted literature
- US20090004174A1 Fusion Proteins Public/Granted day:2009-01-01
Information query